Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P04155 (
pS2
)
1,234
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Mitogen- and stress-activated protein kinases 1 and 2 (MSK1 and
MSK2
), activated downstream of the ERK- and p38-mitogen-activated protein kinase pathways are involved in cell survival, proliferation and differentiation. Following mitogenic or stress stimuli, they mediate the nucleosomal response, which includes phosphorylation of histone H3 at serine 10 (H3S10ph) coupled with transcriptional activation of immediate-early genes. While MSK1 and
MSK2
are closely related, their relative roles may vary with cellular context and/or stimuli. However, our knowledge of
MSK2
recruitment to immediate-early genes is limited, as research has primarily focused on MSK1. Here, we demonstrate that both MSK1 and
MSK2
, regulate the phorbol ester 12-O-tetradecanoylphorbol-13-acetate induced expression of the breast cancer marker gene,
trefoil factor 1
(
TFF1
), by phosphorylating H3S10 at its 5' regulatory regions. The MSK-mediated phosphorylation of H3S10 promotes the recruitment of 14-3-3 isoforms and BRG1, the ATPase subunit of the BAF/PBAF remodeling complex, to the enhancer and upstream promoter elements of
TFF1
. The recruited chromatin remodeling activity leads to the RNA polymerase II carboxy-terminal domain phosphorylation at the
TFF1
promoter, initiating
TFF1
expression in MCF-7 breast cancer cells. Moreover, we show that MSK1 or
MSK2
is recruited to
TFF1
regulatory regions, but as components of different multiprotein complexes.
...
PMID:Mitogen- and stress-activated protein kinases 1 and 2 are required for maximal trefoil factor 1 induction. 2367 62